Patients with chronic rhinosinusitis with nasal polyps saw improvements across all endpoints with tezepelumab, according to an abstract presented here. Results were seen as early as 2 and 4 weeks, ...

Keep reading to learn how nasal sumatriptan works, who could benefit, and how it compares with other types of sumatriptan.

Detailed price information for Lyra Therapeutics Inc (LYRA-Q) from The Globe and Mail including charting and trades.

Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...

Research and development expenses were $21.8 million for the quarter ended December 31, 2024, compared to $11.6 million for the same period in 2023. The increase of $10.2 million was primarily driven ...